Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- CheckyesterdayChange DetectedNew revision adds sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with Document Section and Study Status. The update also notes that a Quality Control Review Has Not Concluded and shows a Returned date of 2026-05-19.SummaryDifference0.7%

- Check8 days agoChange DetectedA new revision entry v3.5.4 was added to the page's revision history, and the previous revision v3.5.3 was removed from the history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe revision/version indicator for this page updated from **v3.5.2** to **v3.5.3**, reflecting a small technical release with no substantive change to the clinical trial information shown.SummaryDifference0.1%

- Check37 days agoChange DetectedNew content sections were added to the record, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with related document sections and status indicators. The entry shows a revision to v3.5.2 and notes that the quality control review has not concluded.SummaryDifference1%

- Check58 days agoChange DetectedThe history shows the status changed from 'No Results Posted' to 'Results Submitted', indicating that results have been submitted but are not yet posted.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.